Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05741528
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-02-20
First Post:
2023-02-13
Brief Title:
An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication
Sponsor:
Sumitomo Pharma America Inc
Organization:
Sumitomo Pharma America Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-13
First Submit QC Date:
February 13 2023
Study First Post Date:
2023-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-16
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL